简体中文  |  English
 
Search
Home News Products R&D Manufacture Career Contact
News

Company News
Industrial News
Home > News
Lonzeal won six intrenational registration in 2011
Issues time:2011-12-31  |  Oriqin:  |  Scan166Time
 

In the past 2011, Lonzeal Pharmaceticals has achieved following six international registration / certification, which is a strong proof of the high standard GMP system and the good quality of our API products. DMF for Lamivudine and Emtricitabine are ready for customer review and qualification.

China GMP

South Africa MCC Registration

World Health Organization PreQualification (WHO PQ) Certifed

Brazil ANVISA Registration and Site GMP Inspection

India DCGI Registration

Russia ROSZDRAVNADZOR Registration

Lamivudine: WHO APIMF 112, FDA DMF 22982

Emtricitabine: FDA DMF 24975 

 

Friendly Link
Powered by:Yanzhilu